Overview
Join a (MASH/NASH) Fatty Liver Research Study
Researchers are studying a new medication called pegozafermin to see if it can help treat Metabolic Dysfunction-Associated Steatohepatitis (MASH), previously called Nonalcoholic Steatohepatitis (NASH), a form of fatty liver disease that can lead to liver damage over time.
In this clinical trial, participants will receive either pegozafermin or a placebo (a study treatment with no active medication). The goal of the study is to learn whether pegozafermin can improve liver health and reduce liver scarring over a treatment period of about 52 weeks (one year).
Researchers will compare liver biopsy results from the beginning of the study and after one year to see whether the treatment helps improve the condition of the liver.
If you qualify, you may receive study-related care and monitoring at no cost, and your participation may help researchers learn more about potential new treatments for MASH.
About the Study
We are currently seeking patients with fatty liver for research studies focused on advancing treatments for Metabolic Dysfunction-Associated Steatohepatitis (MASH), also known as Nonalcoholic Steatohepatitis (NASH).
A Pegozafermin Study
This study is testing a new type of treatment that uses gene silencing to target MASH. This research is focused on people who have specific genetic risk factors for the disease.
By participating, you could help advance the development of new and effective treatment options for MASH/NASH.
Who Can Join
You may be able to participate if you:
- Have a BMI of 25 or higher
- Have been diagnosed with MASH (also called NASH) with liver scarring (fibrosis)
- Have not had a liver transplant
You may not be eligible if you:
- Have other serious liver diseases besides MASH
- Have had bariatric (weight-loss) surgery in the past 5 years
- Have a history of pancreatitis
- Have recently taken certain medications known to affect the liver
- Have used investigational medications for MASH/NASH within the past 6 months
Not sure if you qualify? That’s okay.
A member of our recruitment team will review your medical history and medications with you to see if this study may be right for you.
What to Expect
Study Duration
This study lasts about 3 years.
Study Visits
Participants will attend approximately 13 in-person study visits and complete about 4 phone check-ins with the research team.
Compensation
Participants may receive compensation up to $2,600 for time and travel related to study participation.
Procedures During the Study
If you qualify and choose to participate, you may be asked to:
- Undergo a liver biopsy so researchers can study liver health
- Complete up to 3 MRI scans to help evaluate the liver
- Attend scheduled study visits and phone check-ins with the research team
The study team will explain all procedures, visits, and requirements in detail before you decide whether to participate.